Paul Tudor Jones's RGNX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 24,310 shares of REGENXBIO Inc. (RGNX) worth $203,718, representing 0.00% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in RGNX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2017, adding 50,730 shares. Largest reduction occurred in Q2 2017, reducing 50,730 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's REGENXBIO (RGNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly REGENXBIO (RGNX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +24,310 | New Buy | 24,310 | $14.40 |
| Q2 2025 | -24,123 | Sold Out | 0 | $0.00 |
| Q1 2025 | +24,123 | New Buy | 24,123 | $7.15 |
| Q4 2024 | -24,815 | Sold Out | 0 | $0.00 |
| Q3 2024 | -1,592 | Reduce 6.03% | 24,815 | $10.49 |
| Q2 2024 | +26,407 | New Buy | 26,407 | $11.70 |
| Q4 2023 | -22,694 | Sold Out | 0 | $0.00 |
| Q3 2023 | +9,639 | Add 73.83% | 22,694 | $16.46 |
| Q2 2023 | -12,397 | Reduce 48.71% | 13,055 | $19.99 |
| Q1 2023 | +14,342 | Add 129.09% | 25,452 | $0.02 |
| Q4 2022 | -2,791 | Reduce 20.08% | 11,110 | $0.02 |
| Q3 2022 | +13,901 | New Buy | 13,901 | $26.40 |
| Q2 2022 | -12,317 | Sold Out | 0 | $0.00 |
| Q1 2022 | +12,317 | New Buy | 12,317 | $33.21 |
| Q2 2021 | -12,768 | Sold Out | 0 | $0.00 |
| Q1 2021 | +12,768 | New Buy | 12,768 | $34.15 |
| Q2 2017 | -50,730 | Sold Out | 0 | $0.00 |
| Q1 2017 | +50,730 | New Buy | 50,730 | $19.30 |
| Q4 2015 | -31,150 | Sold Out | 0 | $0.00 |
| Q3 2015 | +31,150 | New Buy | 31,150 | $22.02 |
Paul Tudor Jones's REGENXBIO Investment FAQs
Paul Tudor Jones first purchased REGENXBIO Inc. (RGNX) in Q3 2015, acquiring 31,150 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held REGENXBIO Inc. (RGNX) for 21 quarters since Q3 2015.
Paul Tudor Jones's largest addition to REGENXBIO Inc. (RGNX) was in Q1 2017, adding 50,730 shares worth $979,000.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 24,310 shares of REGENXBIO Inc. (RGNX), valued at approximately $203,718.
As of the Q1 2026 filing, REGENXBIO Inc. (RGNX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in REGENXBIO Inc. (RGNX) was 50,730 shares, as reported at the end of Q1 2017.